Find clinical trials for COVID-19 in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Communicable Diseases
Coronavirus Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Tract Infections

COVID-19 trials near Baltimore, MD, USA:

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics (COV19-APTP-B)

that suggests the potential for clinical benefit of COVID-19 patients.1. Treat Infection of Multiple Gene Mutation COVID-19...

Active, not recruiting
Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection

Early Phase 1

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

North Bethesda, Maryland, United States

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3


Washington, District of Columbia, United States and 106 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 123 other locations

COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...

COVID Long-Haul
Other: Ultra-High Resolution Computed Tomography (CT) Scan
Other: Magnetic Resonance Imaging
Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3


Silver Spring, Maryland, United States and 17 other locations

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Annapolis, Maryland, United States and 28 other locations

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Device: RD-X19
Device: Sham

Annapolis, Maryland, United States and 47 other locations

Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.

Active, not recruiting
Diagnostic Test: Nasopharyngeal swab
Diagnostic Test: Fingerstick

Millersville, Maryland, United States and 6 other locations

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Baltimore, Maryland, United States and 5 other locations

mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...

Active, not recruiting
ARDS, Human
Other: Placebo
Biological: Longeveron Mesenchymal Stem Cells (LMSCs)

Phase 1


Baltimore, Maryland, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems